We tested whether it is possible to selectively block pain signals in the orofacial area by delivering the permanently charged lidocaine derivative QX-314 into nociceptors via TPRV1 channels. We examined the effects of co-applied QX-314 and capsaicin on nociceptive, proprioceptive, and motor function in the rat trigeminal system. QX-314 alone failed to block voltage-gated sodium channel currents (I Na ) and action potentials (APs) in trigeminal ganglion (TG) neurons. However, co-application of QX-314 and capsaicin blocked I Na and APs in TRPV1-positive TG and dental nociceptive neurons, but not in TRPV1-negative TG neurons or in small neurons from TRPV1 knock-out mice. Immunohistochemistry revealed that TRPV1 is not expressed by trigeminal motor and trigeminal mesencephalic neurons. Capsaicin had no effect on rat trigeminal motor and proprioceptive mesencephalic neurons and therefore should not allow QX-314 to enter these cells. Co-application of QX-314 and capsaicin inhibited the jaw-opening reflex evoked by noxious electrical stimulation of the tooth pulp when applied to a sensory but not a motor nerve, and produced long-lasting analgesia in the orofacial area. These data show that selective block of pain signals can be achieved by co-application of QX-314 with TRPV1 agonists. This approach has potential utility in the trigeminal system for treating dental and facial pain. Ó
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Introduction
Local anesthetics (LAs) abolish the transmission of nociceptive information to the central nervous system (CNS) by blocking voltage-gated sodium channels (VGSCs) and thereby prevent the generation and propagation of action potentials (APs) [6] . Most LAs in clinical use are tertiary amines that under physiological conditions exist in a mixture of protonated and uncharged base forms [5] . The uncharged hydrophobic form of LAs penetrates through the membrane of all neurons, so that in addition to blocking pain signals, LAs produce general numbness from the block of low-threshold sensory nerves, as well deficits in motor function, and a block of autonomic nerves [3, 4, 15, 30] .
Selective block of pain signals might be possible either by targeting certain sodium channels that are present only in pain-sensing neurons [7, 12, 20] or by delivering sodium channel blockers selectively to pain-sensing neurons. One strategy is to deliver a permanently charged sodium channel blocker such as QX-314 (N-ethyl-lidocaine) by entry through large-pore ion channels selectively expressed in nociceptive neurons [33] . The transient receptor potential vanilloid 1 (TRPV1) channel is a primary nociceptive transducer in pain-sensing neurons, activated by noxious heat (>43°C), capsaicin, protons and endocannabinoids [8, 36] . A recent study demonstrated that the pore of TRPV1 channels, when opened by the TRPV1 channel agonist capsaicin, might be large enough to deliver QX-314 or other large molecule selectively into nociceptive neurons [11, 22] Abbreviations: APs, action potentials; CNS, central nervous system; dEMG, digastric electromyogram; DiI, 1,1 0 -dioctadecyl-3,3,3 00 3 0 -teramethylindo-carbocyanine perchlorate; DRG, dorsal root ganglia; I Na , voltage-gated sodium channel currents; LAs, local anesthetics; TG, trigeminal ganglion; TRPV1, transient receptor potential vanilloid 1; VGSCs, voltage-gated sodium channels; Vmes, trigeminal mesencephalic nucleus; Vmot, trigeminal motor nucleus; V rest , resting membrane potential.
